SCHEMBL222182

SCHEMBL222182

C=S(=C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72745 0.83
SCHEMBL3517554 0.82
SCHEMBL4420181 0.77
SCHEMBL7764075 0.77
Methane SCHEMBL2913020 0.77
Hydrochloric Acid SCHEMBL6744530 0.77
Benzene SCHEMBL73337 0.68 TP53 (0.33)
Benzene SCHEMBL5194700 0.68 TP53 (0.33)
SCHEMBL261473 0.67
SCHEMBL10978193 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154504-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2025-05-15 US claimed
EP-4479535-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA ProQR Therapeutics II B.V. (NL) 2024-12-25 EP claimed
CN-117374384-A Polymer gel electrolyte and preparation method thereof 河南省法恩莱特新能源科技有限公司 2024-01-09 CN claimed
WO-2023152371-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2023-08-17 WO claimed
CN-115737626-A Disinfection spray and preparation method and application thereof 北京宏同堂制药有限公司 2023-03-07 CN claimed
US-20230039928-A1 Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease PROQR THERAPEUTICS II B.V. (NL) 2023-02-09 US claimed
EP-4081638-A1 ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE ProQR Therapeutics II B.V. (NL) 2022-11-02 EP claimed
CN-113736162-A High-degradation modified plastic particle 安徽成龙塑业科技有限公司 2021-12-03 CN claimed
WO-2021130313-A1 ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE PROQR THERAPEUTICS II B.V. (NL) 2021-07-01 WO claimed
CN-110934776-A Titanium dioxide composite material coated with polytrifluoropropylmethylsiloxane and preparation method and application thereof 中南林业科技大学 2020-03-31 CN claimed
CN-110465618-A A kind of preparation method of high-strength environment-friendly clay green-sand HANSHAN RONGSHENG MACHINERY CASTING CO LTD 2019-11-19 CN claimed
CN-104810546-A Electrolyte for lithium sulfur battery, and preparation method thereof NO 63971 TROOPS PLA 2015-07-29 CN claimed
EP-1163252-A4 COMPOSITIONS, KITS, AND METHODS RELATING TO THE HUMAN FEZ1 GENE, A NOVEL TUMOR SUPPRESSOR GENE UNIV JEFFERSON (US) 2004-04-07 EP claimed
EP-1163252-A2 COMPOSITIONS, KITS, AND METHODS RELATING TO THE HUMAN FEZ1 GENE, A NOVEL TUMOR SUPPRESSOR GENE Thomas Jefferson University (US) 2001-12-19 EP claimed
WO-2000050565-A2 COMPOSITIONS, KITS, AND METHODS RELATING TO THE HUMAN FEZ1 GENE, A NOVEL TUMOR SUPPRESSOR GENE THOMAS JEFFERSON UNIVERSITY (US) 2000-08-31 WO claimed
EP-0354345-B1 Gelatin granules, process and apparatus for their preparation STOESS & CO GELATINE (DE) 1993-12-01 EP claimed
EP-0560831-A1 A TWO-COMPARTMENT SYRINGE ASSEMBLY AND A METHOD OF PRODUCING A TWO-COMPARTMENT SYRINGE ASSEMBLY MEDINJECT A/S (DK) 1993-09-22 EP claimed
WO-1992010225-A1 A TWO-COMPARTMENT SYRINGE ASSEMBLY AND A METHOD OF PRODUCING A TWO-COMPARTMENT SYRINGE ASSEMBLY MEDINJECT A/S (DK) 1992-06-25 WO claimed
US-20260146249-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP VICO THERAPEUTICS B.V. (NL) 2026-05-28 US disclosed
US-4059610-A Process for preparing isocyanic acid derivatives KAO SOAP CO., LTD. (JA) 1977-11-22 US disclosed